Palo Alto Investors’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Palo Alto Investors’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,909	Closed	-$735K	–	47
2025 Q2	$735K	Hold	8,909	–	–	0.16%	40
2025 Q1	$704K	Hold	8,909	–	–	0.13%	38
2024 Q4	$1.49M	Hold	8,909	–	–	0.23%	31
2024 Q3	$837K	Hold	8,909	–	–	0.11%	37
2024 Q2	$878K	Hold	8,909	–	–	0.1%	35
2024 Q1	$1.37M	Hold	8,909	–	–	0.15%	34
2023 Q4	$1.04M	Buy	+8,909	New	+$1.39M	0.09%	29

Other funds holding YARW

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Palo Alto Investors's YARW Position: Q3 2025 in Review

Palo Alto Investors sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2025, closing a stake of 8,909 shares — an estimated $735K sold.

Palo Alto Investors first reported a position in YARW in Q4 2023 and held it in 7 quarters. The position peaked at $1.49M in Q4 2024. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

Palo Alto Investors reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Palo Alto Investors sold 8,909 Yarrow Bioscience, Inc. Common Stock shares in Q3 2025, an estimated $735K.
Palo Alto Investors first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2023 and held it in 7 quarters.
Palo Alto Investors's Yarrow Bioscience, Inc. Common Stock position peaked at $1.49M in Q4 2024.
34 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2025.

Based on Palo Alto Investors's 13F filing for Q3 2025, filed 14 Nov 2025.